Fundamentals for Shield Therapeutics ( stx )
Current Price: 0.02
Market Cap: 16.17m
Price / Net Assets: 2.98
Internal Rate of Return: -21.68%
PE10 Ratio: -0.9
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | Average |
|---|---|---|---|---|---|---|
| Revenue (m) | £4.47m | £1.52m | £10.39m | £0.72m | £11.88m | £6m |
| Revenue Growth | 194.08% | -85.37% | 1,343.06% | -93.94% | - | 339% |
| Profit / Loss | £-40.44m | £-19.68m | £-2.63m | £-8.8m | £-1.79m | £-15m |
| Profit Increase/Decrease | 105.49% | 648.29% | -70.11% | 391.62% | - | 269% |
| Profit / Sales Ratio | - | - | - | - | - | 0% |
| Earnings per Share | £-0.17 | £-0.10 | £-0.02 | £-0.08 | £-0.02 | £-0.08 |
| Total Debt | £16.64m | £3.72m | £2.25m | £4.17m | £3.10m | £5.98m |
| Net Assets | £5.43m | £40.69m | £30.28m | £32.15m | £40.43m | £29.80m |
| Debt / Asset Ratio | 75.40% | 8.38% | 6.92% | 11.48% | 7.12% | 7.12% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0.00x |